Iome Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Liquidation

Iome Bio General Information

Description

Developer of microbiome-based mechanisms designed to develop drugs for immuno-oncology. The company's technology offers an approach through a targeted mode of action downstream of the microbiome's action and provides amplification of the signal with first-in-class monoclonal antibodies, enabling cancer patients to overcome cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Paul Strauss Center
  • 3, Rue de la Porte de l Hopital
  • 67000 Strasbourg
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Paul Strauss Center
  • 3, Rue de la Porte de l Hopital
  • 67000 Strasbourg
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iome Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 20-Jul-2024 Completed Bankruptcy: Liquidation
5. Secondary Transaction - Private Completed Startup
4. Early Stage VC (Series A) 15-Jun-2023 Cancelled Startup
3. Early Stage VC 14-Jun-2022 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Iome Bio’s complete valuation and funding history, request access »

Iome Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
P2 Preference Shares
To view Iome Bio’s complete cap table history, request access »

Iome Bio Patents

Iome Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024038095-A1 Novel anti-rgmb antibodies Inactive 16-Aug-2022

Iome Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Iome Bio FAQs

  • When was Iome Bio founded?

    Iome Bio was founded in 2020.

  • Where is Iome Bio headquartered?

    Iome Bio is headquartered in Strasbourg, France.

  • What is the size of Iome Bio?

    Iome Bio has 7 total employees.

  • What industry is Iome Bio in?

    Iome Bio’s primary industry is Drug Discovery.

  • Is Iome Bio a private or public company?

    Iome Bio is a Private company.

  • What is Iome Bio’s current revenue?

    The current revenue for Iome Bio is .

  • How much funding has Iome Bio raised over time?

    Iome Bio has raised $7.27M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process